HN1998000102A - Composiciones solubilizadas de sertralina - Google Patents

Composiciones solubilizadas de sertralina

Info

Publication number
HN1998000102A
HN1998000102A HN1998000102A HN1998000102A HN1998000102A HN 1998000102 A HN1998000102 A HN 1998000102A HN 1998000102 A HN1998000102 A HN 1998000102A HN 1998000102 A HN1998000102 A HN 1998000102A HN 1998000102 A HN1998000102 A HN 1998000102A
Authority
HN
Honduras
Prior art keywords
soltrilized
sertralina
compositions
present
invention refers
Prior art date
Application number
HN1998000102A
Other languages
English (en)
Inventor
Pfizer Products Inc
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HN1998000102(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of HN1998000102A publication Critical patent/HN1998000102A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A COMPOSICIONES SOLUBILIZADAS DE SERTRALINA.
HN1998000102A 1997-07-01 1998-07-01 Composiciones solubilizadas de sertralina HN1998000102A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5141397P 1997-07-01 1997-07-01

Publications (1)

Publication Number Publication Date
HN1998000102A true HN1998000102A (es) 1999-01-08

Family

ID=21971159

Family Applications (1)

Application Number Title Priority Date Filing Date
HN1998000102A HN1998000102A (es) 1997-07-01 1998-07-01 Composiciones solubilizadas de sertralina

Country Status (34)

Country Link
EP (1) EP0999829A1 (es)
JP (1) JP2000514100A (es)
KR (1) KR100366373B1 (es)
CN (1) CN1261794A (es)
AP (1) AP1192A (es)
AR (3) AR015917A1 (es)
AU (1) AU742535B2 (es)
BG (1) BG103918A (es)
BR (1) BR9810739A (es)
CA (1) CA2290974C (es)
CO (1) CO4940495A1 (es)
DZ (1) DZ2548A1 (es)
EA (1) EA002481B1 (es)
HN (1) HN1998000102A (es)
HR (1) HRP980377A2 (es)
HU (1) HUP0002236A3 (es)
ID (1) ID23429A (es)
IL (1) IL133076A (es)
IS (1) IS5260A (es)
MA (1) MA24587A1 (es)
NO (1) NO996520L (es)
OA (1) OA11243A (es)
PA (1) PA8454301A1 (es)
PE (1) PE97199A1 (es)
PL (1) PL337804A1 (es)
SK (1) SK181099A3 (es)
TN (1) TNSN98124A1 (es)
TR (1) TR199903297T2 (es)
TW (1) TW550087B (es)
UA (1) UA67741C2 (es)
UY (1) UY25071A1 (es)
WO (1) WO1999001120A1 (es)
YU (1) YU68299A (es)
ZA (1) ZA985708B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43702A (sh) 1999-12-23 2004-11-25 Pfizer Products Inc. Farmaceutske kompozicije koje obezbeđuju povećanje koncentracije leka
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
CA2420535A1 (en) 2000-08-30 2002-03-07 Mary Tanya Am Ende Sustained release formulations for growth hormone secretagogues
US20040191207A1 (en) * 2003-03-31 2004-09-30 Lipari John M. Alpha-hydroxy acid ester drug delivery compositions and methods of use
WO2008110268A1 (en) * 2007-03-12 2008-09-18 Dsm Ip Assets B.V. Cosmetic compositions
CA2771403C (en) 2009-08-19 2015-02-24 Eisai R&D Management Co. Ltd. Quinoline derivative-containing pharmaceutical composition
WO2011081118A1 (ja) * 2009-12-29 2011-07-07 興和株式会社 経口投与用医薬組成物
CN102711762A (zh) * 2009-12-29 2012-10-03 兴和株式会社 口服用固体医药组合物
CN109908354A (zh) * 2017-12-12 2019-06-21 万特制药(海南)有限公司 盐酸舍曲林口服浓缩液及其制备工艺
CN114894736B (zh) * 2022-05-20 2025-03-21 中化地质矿山总局地质研究院 一种氯化物型卤水中硝酸根的测定方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
DE69004529T2 (de) * 1989-08-30 1994-02-24 Pfizer Verwendung von Sertralin zur Behandlung von Abhängigkeiten von chemischen Stoffen.
ZA97976B (en) * 1996-04-05 1997-08-18 Alza Corp Uniform drug delivery theraphy.

Also Published As

Publication number Publication date
CN1261794A (zh) 2000-08-02
JP2000514100A (ja) 2000-10-24
PA8454301A1 (es) 2000-09-29
HUP0002236A2 (hu) 2003-08-28
EP0999829A1 (en) 2000-05-17
AR040280A2 (es) 2005-03-23
NO996520D0 (no) 1999-12-28
AU742535B2 (en) 2002-01-03
IS5260A (is) 1999-11-19
IL133076A (en) 2003-12-10
EA002481B1 (ru) 2002-06-27
KR20010013365A (ko) 2001-02-26
NO996520L (no) 2000-02-29
TNSN98124A1 (fr) 2005-03-15
ZA985708B (en) 2000-01-10
UA67741C2 (uk) 2004-07-15
YU68299A (sh) 2002-06-19
CA2290974C (en) 2004-04-27
SK181099A3 (en) 2000-07-11
OA11243A (en) 2003-07-24
PE97199A1 (es) 1999-10-05
DZ2548A1 (fr) 2003-02-08
WO1999001120A1 (en) 1999-01-14
BG103918A (en) 2000-07-31
AP9801280A0 (en) 1998-06-30
CO4940495A1 (es) 2000-07-24
ID23429A (id) 2000-04-20
AP1192A (en) 2003-07-23
IL133076A0 (en) 2001-03-19
HRP980377A2 (en) 1999-04-30
KR100366373B1 (ko) 2003-01-14
TR199903297T2 (xx) 2000-07-21
TW550087B (en) 2003-09-01
UY25071A1 (es) 2000-12-29
EA199900962A1 (ru) 2000-08-28
BR9810739A (pt) 2000-09-12
PL337804A1 (en) 2000-09-11
MA24587A1 (fr) 1998-12-31
AR015917A1 (es) 2001-05-30
CA2290974A1 (en) 1999-01-14
AU7544898A (en) 1999-01-25
AR040279A2 (es) 2005-03-23
HUP0002236A3 (en) 2003-12-29

Similar Documents

Publication Publication Date Title
HN1999000089A (es) Formulaciones de ziprasidona
HN1998000086A (es) Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
HN1998000036A (es) Compuesto de pirazina
HN1998000011A (es) Derivados de acidos arilsulfonilaminohidroxamicos
HN1999000155A (es) 4-carboxiamino-2-metil-1,2,3,4-tetrahidroquinolinas
HN1997000090A (es) Compuestos de piridilpirrol
HN1997000023A (es) Derivados de lactama
HN1997000166A (es) 1-arilpirazoles plaguicidas
HN1999000066A (es) Formulaciones farmaceuticas
HN1998000132A (es) Combinaciones terapeuticas
HN1998000124A (es) Terapia de combinacion
HN1998000057A (es) Derivados de nicotinamida
HN1997000126A (es) Derivados de indazol
HN1998003689A (es) Azetidinas
HN1997000097A (es) Piridinas condensadas con heterociclicos
HN1998000030A (es) 2-amino-6-(4fenoxi-2-sustituido)-piridinas sustituidas
HN1998000106A (es) Composiciones parenterales de alatroflaxacino
HN1998000158A (es) Isoquinolinas
HN1998000028A (es) Otropisomeros de 3 heteroaril - 4 (3h) - quinazolinonas.
HN1998000199A (es) Agentes terapeuticos
HN1998000045A (es) Composiciones farmaceuticas
HN1998000193A (es) Compuestos de triazina
HN1998000165A (es) Polimorfos dofetilina
HN1999000202A (es) Derivados de higromicina
HN1997000119A (es) Formulaciones repelente